Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial
Conclusions
Ten day sequential and modified bismuth quadruple therapies are both highly effective as empirical firstline therapies for H pylori in Chinese patients.
ClinicalTrials.gov
NCT 01760824
Source: Gut - Category: Gastroenterology Authors: Liu, K. S. H., Hung, I. F. N., Seto, W. K. W., Tong, T., Hsu, A. S. J., Lam, F. Y. F., But, D. Y. K., Wong, S. Y., Leung, W. K. Tags: Helicobacter pylori Source Type: research
More News: Amoxicillin | Biaxin | Clarithromycin | Esomeprazole | Gastroenterology | Helicobacter Pylori | Metronidazole | Nexium | Study | Tetracycline